Employees: 02 (2023.0)Legal category: 5785Size: PMECreation date: 2019-06-14 (6 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHAMONIX-MONT-BLANC (74400), Haute-Savoie
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'AIGUILLE DU MIDI : revenue, balance sheet and financial ratios
PHARMACIE DE L'AIGUILLE DU MIDI is a French company
founded 6 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHAMONIX-MONT-BLANC (74400),
this company of category PME
shows in 2024 a net income positive of 66 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'AIGUILLE DU MIDI (SIREN 853122554)
Indicator
2024
2023
2021
2020
Revenue
N/C
N/C
N/C
N/C
Net income
66 249 €
154 129 €
273 221 €
-96 024 €
EBITDA
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, PHARMACIE DE L'AIGUILLE DU MIDI generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
66 249 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 232%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 26%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
231.711%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
26.117%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'AIGUILLE DU MIDI
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2023
2024
Debt ratio
25933.031
343.963
158.237
231.711
Financial autonomy
0.343
19.709
35.417
26.117
Repayment capacity
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
Sector positioning
Debt ratio
231.712024
2021
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE DE L'AIGUILLE D... (231.71) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
26.12%2024
2021
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of PHARMACIE DE L'AIGUILLE D... (26.1%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 212.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
212.042
Liquidity indicators evolution PHARMACIE DE L'AIGUILLE DU MIDI
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2023
2024
Liquidity ratio
167.419
265.363
211.901
212.042
Interest coverage
None
None
None
None
Sector positioning
Liquidity ratio
212.042024
2021
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Good-16 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE L'AIGUILLE D... (212.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE L'AIGUILLE DU MIDI in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE L'AIGUILLE DU MIDI is estimated at
924 885 €
(range 644 075€ - 1 383 680€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
644k€924k€1383k€
924 885 €Range: 644 075€ - 1 383 680€
NAF 5 année 2024
Valuation method used
Net Income Multiple
66 249 €
×
14.0x
=924 885 €
Range: 644 075€ - 1 383 681€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'AIGUILLE DU MIDI with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'AIGUILLE DU MIDI
What is the revenue of PHARMACIE DE L'AIGUILLE DU MIDI ?
The revenue of PHARMACIE DE L'AIGUILLE DU MIDI is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L'AIGUILLE DU MIDI profitable?
Yes, PHARMACIE DE L'AIGUILLE DU MIDI generated a net profit of 66 k€ in 2024.
Where is the headquarters of PHARMACIE DE L'AIGUILLE DU MIDI ?
The headquarters of PHARMACIE DE L'AIGUILLE DU MIDI is located in CHAMONIX-MONT-BLANC (74400), in the department Haute-Savoie.
Where to find the tax return of PHARMACIE DE L'AIGUILLE DU MIDI ?
The tax return of PHARMACIE DE L'AIGUILLE DU MIDI is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'AIGUILLE DU MIDI operate?
PHARMACIE DE L'AIGUILLE DU MIDI operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart